Active, Not Recruiting
Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older
NCT05304351
- Conditions
- Chickenpox, DNA Virus Infections, Herpes Zoster, +5 more
- Locations
-
- Curevo Investigational Site Tempe, Arizona, United States
- Curevo Investigational Site Coral Gables, Florida, United States
- Curevo Investigational Site Tampa, Florida, United States
- Curevo Investigational Site Oak Brook, Illinois, United States